A UK causal modelling study estimates that pre-hospital emergency anaesthesia and intubation for the right major trauma patients would cut their 30-day mortality by 10.3%, or around 170 deaths prevented each year across the UK. For anyone assessing trauma patients before hospital, the message is about recognising who needs a critical care team, early.
Why this matters
Trauma is the leading cause of death in people under 40 in England and Wales. Securing the airway is a top priority, but whether to intubate at scene or wait for the emergency department has been argued over for decades.
In the UK, pre-hospital emergency anaesthesia (PHEA, meaning drug-assisted intubation outside hospital) is delivered by physician-paramedic critical care teams, mostly through air ambulance charities. Ground crews do not provide it.
The evidence has been weak. The only randomised trial, published in 2010, covered 312 patients with severe traumatic brain injury. It showed better neurological outcome with paramedic intubation (51% versus 39% favourable) but no mortality difference. Observational studies were rated very low quality, partly because sicker patients are both more likely to be intubated and more likely to die. That bias made intubation look harmful.
A new randomised trial is near impossible, so the researchers turned to causal modelling of registry data.
What the researchers did
The study was led by UCL and the Severn Major Trauma Network, with Dr Amy Nelson as joint first author and Professor Parashkev Nachev and Dr Julian Thompson as joint senior authors. It appeared in The Lancet Respiratory Medicine in February 2026, funded by the Wellcome Trust and the NIHR UCLH Biomedical Research Centre.
The data came from the Trauma Audit and Research Network (TARN), the UK national trauma registry, now the National Major Trauma Registry. The team extracted every major trauma patient admitted to Southmead Hospital in Bristol across two periods: 23 February 2012 to 31 March 2017 (3,882 patients) and 1 April 2017 to 13 November 2019 (2,585 patients). That gave 6,467 adults and children. Around 10% were intubated at scene and 10% died within 30 days.
From 3,301 registry variables, they kept 210 available before hospital. Machine learning models trained on the first period predicted early intubation (at scene or in the emergency department) and 30-day mortality. The second period was an unseen test set.
They then built a simplified model, Intub-8, using eight inputs a crew could gather at scene: GCS with pupil reactivity, pulse rate, respiratory rate, intravenous fluids, age, spinal immobilisation, tranexamic acid, and fall under 2 metres.
Finally, they used doubly robust estimation. This causal inference method models both who gets the treatment and what happens to them, so the estimate holds if either model is right. It asks what would have happened to high-risk patients had they been intubated before hospital.
What they found
The models predicted early intubation and 30-day mortality well from pre-hospital data alone (AUROC 0.943 and 0.867). Intub-8 performed nearly as well (AUROC 0.897). The strongest predictor of early intubation was scene GCS; of death, age.
Patients predicted to need early intubation but not intubated before hospital had 30-day survival of 71.4%, against 94.4% for those not predicted to need it. The gap held whether or not a doctor or HEMS team attended.
In the high-risk group identified by Intub-8 (229 patients), pre-hospital intubation reduced 30-day mortality by 10.3% (95% CI 8.7% to 11.9%). That is a net 28 extra survivors, or 12.2%.
In the low-risk group (2,356 patients) the effect was 0.7%. Intubating everyone regardless of risk gave an average effect of 1.6%. Selection drove the benefit.
Scaled to UK major trauma incidence, the authors project 170 deaths prevented per year (95% CI 148 to 191). For context, major trauma centres are estimated to save around 320 lives a year. The health economic model gives 3,395 QALYs a year, valued at £101 million, against a pre-hospital cost of £221 per intubation. The authors argue this alone justifies the £62.5 million annual cost of UK HEMS.
An unmeasured confounder would need a risk ratio of at least 2.89 for both intubation and death to explain the result away. Complications were not measured.
Strengths and limitations
This is the strongest evidence yet on the question. The dataset is large, the test data were unseen, and the method was built to counter the confounding that undermined older studies.
It remains observational. No model can adjust for what was not recorded: operator skill, scene complexity, dispatch accuracy or judgement. The design is partly circular, because it predicts need for intubation from past clinician decisions.
TARN excludes patients who die before reaching hospital. The authors found only three patients intubated pre-hospital who died before arrival in seven years, all peri-arrest. The larger group who died unseen and un-intubated are missing, which the authors argue makes the estimate conservative.
Only 30-day survival was measured, not neurological outcome, length of stay or complications.
Generalisability is the key caveat. This is one mixed rural and urban UK region where all PHEA is delivered by physician-paramedic teams. It does not tell us what paramedic-only intubation would achieve, nor does it cover offshore or remote settings. The authors suggest benefit might be larger with longer transfers, but that is untested.
What it means for your practice
This paper should not change what you do at the roadside on its own. JRCALC, local protocols and your scope of practice govern airway management. St Emlyn’s called it hypothesis-strengthening rather than practice-changing. That is fair.
- Paramedics and ambulance clinicians: your value is in early recognition and escalation. Low GCS, abnormal pulse or respiratory rate, suspected major haemorrhage and high-energy mechanism carried most weight in the model. Request critical care early, not after a trial of basic airway management.
- First responders and FREC 3: maintain the airway with the tools you have, hand over GCS components and pupils, and make sure enhanced care has been called.
- HEMS and critical care teams: the data support targeted PHEA for high-risk patients, not wider indications. In lower-risk patients the benefit was under 1%.
- Offshore and diver medics: the study did not include your setting. Your plan rests on supraglottic airways, oxygenation, ventilation support and early evacuation under topside medical advice.
- Everyone: Intub-8 is a research tool, not an approved clinical decision aid.
Reflect
- Which signs in a trauma patient would prompt you to request a critical care team, and how early could you identify them?
- How does your service’s escalation pathway for PHEA work, and what delays could you reduce?
- What are the limits of your airway skills, and how do you maintain oxygenation while waiting for enhanced care?
- Why does confounding by indication make older studies of pre-hospital intubation unreliable, and how did this study address it?
Read the original
- The Lancet Respiratory Medicine: Survival effect of prehospital emergency anaesthesia with intubation in risk-stratified patients with major trauma, a causal modelling study, 2026
- UCL News: Breathing tube insertion before hospital admission for major trauma saves lives, February 2026
- North Bristol NHS Trust: Southmead clinicians co-author significant major trauma study, 2026
- St Emlyn’s: Survival effect of prehospital emergency anaesthesia in major trauma, critical appraisal, 2026
- The Resus Room podcast: Airway management in trauma, roadside to resus, with the study authors, 2026
Published 25 October 2026. Last reviewed October 2026.
These summaries are for education and CPD only. They are not clinical guidelines. Always practise within your scope of practice and follow your employer’s protocols and national guidance such as JRCALC and Resuscitation Council UK.